How do you decide?' Cancer patients die waiting for CAR-T therapy

“And people are dying. About 20% of all our patients together are actually dying before they can get CAR-T,” said Krina Patel, director of the myeloma cell therapy program at MD Anderson.

CAR T Cell Therapy May Eliminate Tumor Cells Missed by Surgery

Canadian cancer survivor works with the NRC for broader access to CAR-T therapy - National Research Council Canada

DLBCL Relapse Chances and Treatment Options

CAR T Cell Therapy for The Treatment of Cancer - CancerConnect

Episode 075: Intro to CAR-T, Bispecifics (BiTE), and Autologous Transplant — The Fellow On Call

FDA investigating risk of secondary cancers after CAR-T therapy to treat cancer

FDA approves first T-cell therapy for a solid tumor

CAR T-cell Therapy vs. Bispecific Antibodies

Research project aims to make CAR-T-cell therapy safer and more effective, College of Medicine

Multiple myeloma patients await MSAC verdict on CAR T-cell therapy to manage blood cancer - ABC News

Frontiers From bench to bedside: the history and progress of CAR T cell therapy

Biopharmaceutical Development Program Produces Personalized Anticancer Medicine for Young People with Cancer

Potential solutions for manufacture of CAR T cells in cancer immunotherapy

What is T cell therapy?